Global Pertussis Vaccine Market Research Report 2020
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Manufacturers take the combination of direct Marketing channel and distribution sales in the form, Future sales channels both direct selling and distribution needs with the help of online sales platform.
The market channel is essential to every manufacturer and they are paying more and more attention to their channel building. Firstly, suppliers can build strong sales teams to directly manage their own customers. At the same time, more flexible and attractive channel incentives can be created and channel support can be provided in different ways. At the meantime, customers are concerning more on the product quality and services. So, except all of the distributors and direct marketing, they are also consider their logistics and services, making sure that both products and services are better than the competitors.
The global Pertussis Vaccine market is valued at 7136.1 million US$ in 2020 is expected to reach 7486.8 million US$ by the end of 2026, growing at a CAGR of 0.7% during 2021-2026.
This report focuses on Pertussis Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pertussis Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Pertussis Vaccine market is segmented into
Whole-cell vaccines
Acellular vaccines
Segment by Application
Children
Adults
Global Pertussis Vaccine Market: Regional Analysis
The Pertussis Vaccine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Pertussis Vaccine market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Pertussis Vaccine Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Pertussis Vaccine market include:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
Manufacturers take the combination of direct Marketing channel and distribution sales in the form, Future sales channels both direct selling and distribution needs with the help of online sales platform.
The market channel is essential to every manufacturer and they are paying more and more attention to their channel building. Firstly, suppliers can build strong sales teams to directly manage their own customers. At the same time, more flexible and attractive channel incentives can be created and channel support can be provided in different ways. At the meantime, customers are concerning more on the product quality and services. So, except all of the distributors and direct marketing, they are also consider their logistics and services, making sure that both products and services are better than the competitors.
The global Pertussis Vaccine market is valued at 7136.1 million US$ in 2020 is expected to reach 7486.8 million US$ by the end of 2026, growing at a CAGR of 0.7% during 2021-2026.
This report focuses on Pertussis Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pertussis Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Pertussis Vaccine market is segmented into
Whole-cell vaccines
Acellular vaccines
Segment by Application
Children
Adults
Global Pertussis Vaccine Market: Regional Analysis
The Pertussis Vaccine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Pertussis Vaccine market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Pertussis Vaccine Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Pertussis Vaccine market include:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
